Eric Ostertag, Chief Executive Officer at Poseida Therapeutics, Inc. (PSTX), sold 224,822 shares at $8.34 ($1.9M) on 2021-09-02, disclosed to the SEC on 2021-09-03.
Open-market sale of $1.9M PSTX by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.46 | 24,463 | $207K | 11.0% |
| 2 | $8.46 | 24,463 | $207K | 11.0% |
| 3 | $8.46 | 26,686 | $226K | 12.0% |
| 4 | $8.46 | 26,686 | $226K | 12.0% |
| 5 | $8.34 | 29,299 | $244K | 12.9% |
| 6 | $8.34 | 29,299 |
| $244K |
| 12.9% |
| 7 | $8.34 | 31,963 | $267K | 14.1% |
| 8 | $8.34 | 31,963 | $267K | 14.1% |
| Total | $8.39 avg | 224,822 | $1.9M | 100% |
| Filing → |
| PSTX | SELL | 2021-11-10 | $268K | — | Filing → |
| PSTX | SELL | 2021-10-05 | $208K | — | Filing → |
| PSTX | SELL | 2021-09-22 | $160K | — | Filing → |